Skip to main content
. 2022 Aug 4;11(18):e025198. doi: 10.1161/JAHA.122.025198

Figure 2. Cumulative incidence of venous thromboembolism (VTE) within 30 days of hospitalization by soluble urokinase plasminogen activator receptor (suPAR) tertile.

Figure 2

suPAR categories are defined as follows: first tertile, 0 to 5.2 ng/mL; second tertile, 5.3 to 8.7 ng/mL; and third tertile, 8.8 to 62.7 ng/mL